NUROSENE CHIEF SCIENCE OFFICER PRESENTS AT LEADING DRUG DEVELOPMENT FORUM

Stock Information for NetraMark Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NetraMark Holdings Inc.

CSE Bulletin: Name and Symbol Change - Nurosene Health Inc. (MEND)
INTRODUCING NETRAMARK - A PHARMA AI COMPANY
NUROSENE ANNOUNCES ADVISORY ROLE WITH RARE-X
NUROSENE BUSINESS UPDATE
NUROSENE HEALTH INC. ANNOUNCES CLOSING OF PRIVATE PLACEMENT
NUROSENE HEALTH INC. ANNOUNCES CLOSING OF PRIVATE PLACEMENT
NUROSENE APPOINTS NEUROSURGEON DR. DOUGLAS JAMES COOK AS CHIEF MEDICAL OFFICER
Nurosene Appoints New Advisory Board Member Dhananja Jayalath

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.